Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Electrocardiogram ambulatory, Myocarditis
Clinical narrative: She developed myocarditis; She developed myocarditis. And she still has it. In fact, now it's getting worse; This spontaneous case was reported by a patient family member or friend and describes the occurrence of MYOCARDITIS (She developed myocarditis) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular use) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MYOCARDITIS (She developed myocarditis) (seriousness criterion medically significant) and CONDITION AGGRAVATED (She developed myocarditis. And she still has it. In fact, now it's getting worse). At the time of the report, MYOCARDITIS (She developed myocarditis) had not resolved and CONDITION AGGRAVATED (She developed myocarditis. And she still has it. In fact, now it's getting worse) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Electrocardiogram ambulatory: myocarditis came back.   No vaccines within the past 4 weeks prior to the Moderna vaccine was reported.  No concomitant medications were reported.  The reporter inquired about methods for removing the COVID spike protein from the body of someone who had received the Moderna COVID vaccine.  The reporter and her daughter had received three doses of the Moderna Covid vaccine, including two primary doses and a booster. The patient developed myocarditis and continued to suffer from the condition for three years. It was reported that the patient had never contracted COVID and was dealing with myocarditis which was worsening. Despite being on inflammatory and anti-inflammatory medications, patient's health was deteriorating, as confirmed by a Holter monitor test, which detected new complications. HCP recommended implanting a loop recorder in her chest. It was reported that patient had no cardiac blockages and was otherwise a healthy and slim woman. It was suggested that the vaccine was responsible for her condition. It was reported that for some people, the spike protein naturally dissipates, but for others, it remains and causes ongoing health issues. She reported that doctors had not devised a treatment plan, and she criticized claims that myocarditis primarily affects men aged 19 to 30, asserting that individuals up to the age of 80 had reported similar issues. She sought answers regarding the removal of the spike protein.  She confirmed that neither her daughter nor son-in-law had experienced any other side effects.  She reported that Moderna had known that myocarditis could result from the vaccine but failed to disclose it properly. She mentioned clinical trials she saw on TV, saying that myocarditis had been documented but was reportedly considered a temporary issue in young people. The reporter reiterated that Moderna had known that myocarditis would result from it. The reporter questioned whether the company had a plan to treat vaccine-induced myocarditis, and she also found it strange that both her daughter and her husband had developed the condition.  No treatment medications were reported.    This case was linked to US-MODERNATX, INC.-MOD-2025-786302 (E2B Linked Report).; Reporter's Comments: The benefit -risk relationship of product is not affected by this report.; Sender's Comments:  US-MODERNATX, INC.-MOD-2025-786302:same reporter different patient